L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
K010: Serum creatinine is an unadequate marker of renal insufficiency prevalence in essential hypertension
Journal ArticleDOI
Second denervation in a patient with resistant hypertension.
TL;DR: A 44-year-old woman with no history of interest who presented with four periods of hypertensive crisis characterized by headaches, facial flushing, sweating, palpitations and syncope is presented, to rule out other forms of secondary hypertension and confirm the adherence to the RDN treatment.
Journal ArticleDOI
Prediction of the early response to spironolactone in resistant hypertension by the combination of matrix metalloproteinase-9 activity and arterial stiffness parameters.
Elena Rodríguez-Sánchez,José Alberto Navarro-García,Jennifer Aceves-Ripoll,Laura González-Lafuente,Montserrat Baldan-Martin,Fernando de la Cuesta,Gloria Alvarez-Llamas,Maria G. Barderas,Julian Segura,Luis M. Ruilope,Gema Ruiz-Hurtado +10 more
TL;DR: Combining MMP-9 activity with classical arterial stiffness parameters improves the prediction of the clinical response to spironolactone and might contribute to guide the most appropriate therapeutic decisions for patients with RH.
Journal ArticleDOI
Lercanidipine effectiveness and tolerability profile is not influenced by overweight or body fat increase. the lerzamig study: p2.381
Vivencio Barrios,Alberto Calderón,Angel Navarro,C. Noya,Inmaculada Herranz,Luis Prieto,J. R Tomás,Carlos Escobar,C. Roldan,Luis M. Ruilope +9 more
Journal Article
Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension.
Luis M. Ruilope,Miranda B,Rafael Garcia Robles,Timothy G. Hammond,Joaquín Mariano Mantecón Sancho,Juan C. Romero,Jose L. Rodicio +6 more
TL;DR: It is concluded that patients with essential hypertension, after chronic treatment with captopril, show no inhibition of renin secretion in contrast with the controls and require more angiotensin II to evoke a pressor response during infusion of this peptide.